Ascelia Pharma (Sweden) Price on October 4, 2024
ACE Stock | SEK 2.90 0.11 3.65% |
If you're considering investing in Ascelia Stock, it is important to understand the factors that can impact its price. As of today, the current price of Ascelia Pharma stands at 2.90, as last reported on the 2nd of December, with the highest price reaching 2.93 and the lowest price hitting 2.79 during the day. Ascelia Pharma appears to be very risky, given 3 months investment horizon. Ascelia Pharma AB secures Sharpe Ratio (or Efficiency) of 0.1, which signifies that the company had a 0.1% return per unit of standard deviation over the last 3 months. By analyzing Ascelia Pharma's technical indicators, you can evaluate if the expected return of 0.56% is justified by implied risk. Please makes use of Ascelia Pharma's risk adjusted performance of 0.0875, and Mean Deviation of 3.47 to double-check if our risk estimates are consistent with your expectations.
Ascelia Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Ascelia |
Sharpe Ratio = 0.1041
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ACE | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.42 actual daily | 48 52% of assets are more volatile |
Expected Return
0.56 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Ascelia Pharma is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ascelia Pharma by adding it to a well-diversified portfolio.
Ascelia Pharma Valuation on October 4, 2024
It is possible to determine the worth of Ascelia Pharma on a given historical date. On October 4, 2024 Ascelia was worth 2.26 at the beginning of the trading date compared to the closed value of 2.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ascelia Pharma stock. Still, in general, we apply an absolute valuation method to find Ascelia Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ascelia Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ascelia Pharma's related companies.
Open | High | Low | Close | Volume | |
2.21 | 2.32 | 2.21 | 2.26 | 460,573 | |
10/04/2024 | 2.26 | 2.33 | 2.20 | 2.22 | 630,011 |
2.25 | 2.26 | 2.17 | 2.22 | 418,248 |
Backtest Ascelia Pharma | | | Ascelia Pharma History | | | Ascelia Pharma Valuation | Previous | Next |
Ascelia Pharma Trading Date Momentum on October 4, 2024
On October 07 2024 Ascelia Pharma AB was traded for 2.22 at the closing time. The maximum traded price for the trading interval was 2.26 and the lowest daily price was 2.17 . The daily volume was recorded at 418.2 K. The volume of trading on 7th of October 2024 did not affect price variability. The overall trading delta to the closing price today is 1.80% . |
Ascelia Pharma AB Fundamentals Correlations and Trends
By evaluating Ascelia Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ascelia Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ascelia financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ascelia Pharma Stock history
Ascelia Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ascelia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ascelia Pharma AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ascelia Pharma stock prices may prove useful in developing a viable investing in Ascelia Pharma
Ascelia Pharma AB operates as an oncology focused specialty pharmaceutical company that develops medicines to enhance the life expectancy for people living with cancer and cancer-related diseases in Sweden and Denmark. The company was founded in 2000 and is headquartered in Malm, Sweden. Ascelia Pharma operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 4 people.
Ascelia Pharma Stock Technical Analysis
Ascelia Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ascelia Pharma Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Ascelia Pharma AB cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ascelia Pharma December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Ascelia Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ascelia Pharma shares will generate the highest return on investment. By undertsting and applying Ascelia Pharma stock market strength indicators, traders can identify Ascelia Pharma AB entry and exit signals to maximize returns
Ascelia Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ascelia Pharma's price direction in advance. Along with the technical and fundamental analysis of Ascelia Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ascelia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0875 | |||
Jensen Alpha | 0.4521 | |||
Total Risk Alpha | (0.35) | |||
Sortino Ratio | 0.1081 | |||
Treynor Ratio | 0.7396 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Ascelia Stock Analysis
When running Ascelia Pharma's price analysis, check to measure Ascelia Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascelia Pharma is operating at the current time. Most of Ascelia Pharma's value examination focuses on studying past and present price action to predict the probability of Ascelia Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascelia Pharma's price. Additionally, you may evaluate how the addition of Ascelia Pharma to your portfolios can decrease your overall portfolio volatility.